glp-1 meds list The Agonists and Obesity: How Diabetes Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy US FDA creates 'green list'

When GLP-1 receptor agonists are used with insulin or sulphonylureas, the risk of hypoglycaemia increases, and dose reductions of these medications may be necessary

This meta-analysis showed that, over 398 patients with schizophrenia treated with antipsychotic followed up between 12 and 24 weeks, the GLP-1RAs liraglutide and exenatide were superior to placebo for body weight, waist circumference, BMI and blood pressure 134

Obesity should be treated the same way. Bariatric surgery remains the single most effective weight-loss intervention available, Azagury said, producing average body weight losses of 25% to 35% or more

Average 28.7% body weight loss at 68 weeks at the 12 mg dose (about 71.2 lbs / 32.3 kg average loss)